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Viral RNA synthesis was assayed in HeLa cells transfected with nonviable poliovirus RNA mutated in the
genome-linked protein VPg-coding region. The transfecting RNA was transcribed in vitro from full-length
poliovirus type 1 (Mahoney) cDNA containing a VPg mutagenesis cartridge. Hybridization experiments using
ribonucleotide probes specific for the 3' end of positive- and negative-sense poliovirus RNA indicated that all
mutant RNAs encoding a linking tyrosine in position 3 or 4 of VPg were replicated even though no virus was
produced. VPg, but no VPg precursor, was found to be linked to the 5' end of the newly synthesized RNA.
Encapsidated mutant RNAs were not found in transfected-cell lysates. After extended maintenance of
transfected HeLa cells, a viable revertant of one of the nonviable RNAs was recovered; the revertant lost the
lethal lesion in VPg by restoring the wild-type amino acid, but it retained all other nucleotide changes
introduced during construction of the mutagenesis cartridge. Mutant RNA encoding phenylalanine or serine
rather than tyrosine, the linking amino acid in VPg, was not replicated in transfected cells. A chimeric mutant
containing the VPg-coding region of coxsackievirus within the poliovirus genome was viable but displayed
impaired multiplication. A poliovirus-coxsackievirus chimera lacking a linking tyrosine in VPg was nonviable
and replication-negative. The results indicate that a linkage-competent VPg is necessary for poliovirus RNA
synthesis to occur but that a step in poliovirus replication other than initiation of RNA synthesis can be
interrupted by lethal mutations in VPg.
Poliovirus consists of a messenger-sense, single-stranded
RNA genome approximately 7,440 nucleotides in length
packaged in 60 copies each of the capsid proteins VP1, VP2,
VP3, and VP4 (14, 32). Poliovirus genomic RNA and mRNA
are identical in sequence: they contain a 5'-noncoding region
of 742 bases followed by a 6,627-nucleotide open reading
frame, a 72-base 3' untranslated region, and a 3' polyadeny-
late tract (14, 30, 45). Both RNA species differ, however, in
the structures of their 5' termini. Whereas viral mRNA
terminates in pU, the genomic RNA carries an additional
group, the genome-linked viral protein VPg, at the 5' end (7,
19, 23-25, 27, 28, 44). It has been observed that all newly
synthesized viral RNAs are VPg linked (VPg-pU...) (23) but
that plus strands destined to become mRNA are unlinked
from the 5'-terminal VPg to yield pU..., a process thought to
be catalyzed by a cellular enzyme (2, 6).
VPg is a basic, 22-amino-acid oligopeptide that is linked to
RNA by a phosphodiester bond between the 5'-terminal
uridine residue of the RNA and the 04-hydroxyl group of
tyrosine, the third residue of VPg (1, 31). VPg is not required
for infectivity; the RNA is the only component of the virus
necessary to initiate a productive infection of a susceptible
host cell (44).
VPg is a component of the poliovirus polyprotein (13) and
is released from it by two cleavages at glutamine-glycine
amino acid pairs (22) (Fig. 1). It is not known at what stages
in the replicative cycle these cleavages occur. The cleavage
at the C-terminal glutamine of VPg is very rapid and leads,
together with upstream proteolytic processing, to the emer-
gence of 3AB (3B is VPg; see reference 32), a polypeptide
thought to be a membrane-associated precursor of VPg (34).
The mechanism by which VPg, or a VPg precursor, is
linked to RNA has not been identified. Linkage of the
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protein to positive- and negative-sense RNAs may occur by
different mechanisms, since the negative-sense strands con-
tain poly(U) at their 5' termini, whereas the 5' termini of
positive-sense strands are heteropolymeric.
Despite intensive biochemical and genetic analyses, polio-
virus genome replication remains a poorly understood pro-
cess (17, 36). Replication of poliovirus template RNA in a
cell-free system, a means of simplifying the analysis of the
role individual proteins and cofactors may play in various
stages of RNA replication, has not been achieved. In vitro
systems are complicated because genome replication occurs
on membranes (9, 21, 26, 37-39). Intracellular poliovirus
RNA replication follows the pathway characteristic of other
lytic, single-stranded RNA viruses with messenger-sense
genomes. However, poliovirus and the other members of the
family Picornaviridae employ a strategy of gene expression
common to only a few plus-strand RNA virus families.
Translation of the poliovirus genome yields a single polypep-
tide that is cleaved by viral proteinases to provide structural
and nonstructural polypeptides (10, 22, 41). Among the
virus-specific nonstructural proteins is the primer-dependent
RNA polymerase, 3DPo1, that is probably involved in the
synthesis of negative-sense and positive-sense copies of the
genomic RNA (8, 17, 36). Individual steps ofRNA synthesis,
particularly initiation, are obscure; however, a protein-
nucleotidyl moiety containing VPg or a VPg precursor is
likely to be generated. Whether this is achieved through
uridylylation of polypeptides (37-39) or by cleavage of a
polynucleotide chain (8) remains to be seen (discussed in
references 17 and 36). Regions of VPg, including the nucleic
acid-linking site, are highly conserved among picornaviruses
(3) and thus appear to be under strong selective pressure.
In a membranous replication complex, endogenous VPg
can be uridylylated in vitro to VPg-pUpU, which can be
extended to longer RNA molecules, an observation that was
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FIG. 1. Schematic representation of poliovirus type 1 (Mahoney) and mutant VPgs. The amino acid sequence of the wild-type VPg is given
by the one-letter amino acid code within the boxed region. Mutants are listed below the wild-type sequence, with their amino acid changes
replacing the dashed lines. Construct pT7-VPg37 encodes a 5-residue insertion, as indicated. Some of the mutants contain arginine rather than
lysine at position 10 of VPg; this conservative substitution was the result of construction of the mutagenesis cartridge. Whether infectious
virus was recovered from transfected HeLa cells is shown to the right.
interpreted as suggesting that the uridylylated protein may
serve as a primer for RNA-dependent RNA synthesis (23,
37). Priming of genome synthesis with a nucleotidyl poly-
peptide is not without precedent. For example, nucleotidy-
lated proteins of adenovirus and the DNA bacteriophages
+29 and PRD1 serve as a primers in DNA synthesis (12, 44),
during which they become linked to the genomic DNAs.
Surprisingly, the PRD1 terminal protein shares some amino
acid homology with poliovirus VPg (11, 12).
Whether VPg serves as a signal for encapsidation of virion
RNA into procapsids or is involved in the maturation cleav-
age of VPO to VP4 and VP2 (22) remains to be seen.
Whatever the role of VPg in poliovirus replication, the
construction of mutants by site-directed mutagenesis
seemed a plausible strategy with which to attack the prob-
lem. Accordingly, several poliovirus VPg mutants have been
generated by Kuhn et al. (15, 16) by using cartridge muta-
genesis. Here we report further characterization of these and
newly constructed mutants. Although these studies do not
allow us as yet to assign a function to VPg, our data suggest
that VPg may play a role in RNA synthesis and also in a step
of replication that follows RNA synthesis.
MATERIALS AND METHODS
Cells and viruses. Transfections, virus propagations, and
assays of viral RNA synthesis and VPg-RNA linkage were
performed with R19 HeLa cell monolayers maintained in
Dulbecco modified Eagle medium supplemented with 5%
fetal bovine serum. Poliovirus type 1 (Mahoney strain) stock
used in the experiments was a plaque-purified isolate ob-
tained by transfection of COS-1 cells with pT7XL RNA (42)
or pEV104 DNA (35). Purification of virions and preparation
of viral RNA for sequencing were done as described previ-
ously (29).
Construction of plasmids and transfection of cells. The
construction of mutant cDNAs by using the VPg mutagene-
sis cartridge has been described previously (15, 16). Com-
plementary oligonucleotides encoding mutations were in-
serted into the VPg mutagenesis cartridge contained in the
plasmid pNT15. Putative mutants were screened by dideoxy
sequencing of plasmid DNA (5, 33). BglI (nucleotide 5318)-
to-BglII (nucleotide 5601) fragments from mutant clones
were used to replace the corresponding fragment in the
transcription plasmid pT7-VPgl5, which contains a full-
length clone of type 1 poliovirus under control of the phage
T7 promoter. The sequence of mutants was confirmed by
dideoxy sequencing of RNA transcribed from full-length
clones (33). Transcription of RNA by T7 RNA polymerase
and transfection of cells using DEAE-dextran were done as
previously described (16, 42), except that cells were sup-
ported in Dulbecco modified Eagle medium containing 5%
rather than 10% fetal bovine serum. Mutant RNAs were
considered nonviable if no plaque-forming virus was de-
tected by 48 h posttransfection. One-step growth curve
experiments with viable mutants were done as previously
described (15).
Synthesis of radiolabeled polynucleotide probes. Radioac-
tively labeled probes specific for positive- and negative-
sense poliovirus RNA were prepared by transcription from
restriction endonuclease-digested plasmids containing polio-
virus cDNA downstream from a T7 promoter. Transcription
mixtures contained 1 mCi of [t-32P]ATP (specific activity,
650 Ci/mmol; ICN Radiochemicals, Irvine, Calif.) per ml.
Digestion of 10 ,ug of pT7PV1-2 with PvuII and subsequent
transcription produced a 386-base polyribonucleotide com-
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plementary to the 3' end of positive-sense poliovirus RNA.
KpnI digestion of 10 ,ug of pT7XL, a plasmid derived from
pT7PV1-5 that contains a full-length poliovirus cDNA, al-
lowed transcription of a 70-base polyribonucleotide comple-
mentary to the 3' end of negative-sense poliovirus RNA.
Labeled probes were purified by passage through 2 ml of
Sephadex G-50 (particle size, 20 to 80 ,um) columns.
RNA blotting and hybridization. HeLa cell monolayers in
35-mm dishes were transfected with 200 ng of RNA or were
mock transfected. As a positive control, some monolayers
were transfected with RNA transcribed from plasmid
pT7XL or pT7-VPglS. RNA transcribed from pT7-VPglS
encodes arginine rather than lysine at position 10 of VPg, but
the multiplication of virus derived from VPg15 RNA is
similar to that of wild-type virus, as indicated by one-step
growth experiments. RNA lacking a complete RNA poly-
merase-encoding region was transcribed from PvuII-
digested pT7PV1-5 and served as an additional negative
control. At various times posttransfection, the growth me-
dium was aspirated and the monolayers were rinsed twice
with cold phosphate-buffered saline. Cells were lysed in 200
,ul of lysis buffer (10 mM Tris hydrochloride [pH 7.5], 100
mM NaCl, 1 mM EDTA, 0.2% [vol/vol] Nonidet P-40). The
lysates were clarified by centrifugation at 5,000 x g for 5
min, and the RNA was denatured by the addition of 120 ,ul
20x SSC (lx SSC is 0.15 M NaCl, 0.015 M sodium citrate
[pH 7.0]) (20) and 80 [LI of 37% (wt/vol) formaldehyde
followed by incubation at 60°C for 15 min. RNA was spotted
on Zeta-Probe nylon membranes (Bio-Rad Laboratories,
Richmond, Calif.) with a Micro-Sample filtration manifold
(Schleicher & Schuell, Inc., Keene, N.H.) (40). Prehybrid-
ization of membranes was done in 6 x SSPE (lx SSPE is
0.18 M NaCl, 10 mM sodium phosphate [pH 7.7], 1 mM
EDTA) (20), lOx Denhardt reagent (lx Denhardt reagent is
0.02% Ficoll, 0.02% polyvinylpyrrolidone, 0.02% bovine
serum albumin) (20), 0.75% sodium dodecyl sulfate (SDS),
and 50 ,ug of herring sperm DNA per ml for 2 h at 42°C. The
prehybridization solution was then replaced with hybridiza-
tion solution (6x SSPE, 0.75% SDS, 50% [vol/vol] formam-
ide, 50 ,ug of herring sperm DNA per ml) containing S x 107
cpm of radiolabeled probe. Hybridization was done at 59°C
for 16 h. After two 15-min washes in 6x SSPE-0.3% SDS at
room temperature and two 15-min washes in lx SSPE-
0.75% SDS at 37°C, the degree of hybridization was mea-
sured by exposure of the membranes to XAR-2 film (East-
man Kodak Co., Rochester, N.Y.).
Labeling of VPg-pUp. HeLa cell monolayers in 10-cm
dishes were transfected with 2 ,ug of RNA or were mock
transfected and incubated at 37°C. Nine hours posttransfec-
tion, the medium was aspirated and replaced with medium
containing 2.5 ,ug of dactinomycin per ml. Fifteen minutes
later, 32Pi was added to a concentration of 2 mCi/ml. At 20 h
posttransfection, the medium was aspirated, the monolayers
were rinsed once with cold phosphate-buffered saline, and
the cells were lifted from the plates with trypsin. Cells were
washed once with cold phosphate-buffered saline and lysed
in 200,ul of lysis buffer. Clarified lysates were extracted once
with phenol, ethanol precipitated, and treated with 0.5 mg of
RNase A per ml and 0.2 mg of RNase T1 per ml for 30 min
at 37°C. Immunoprecipitations were done with antiserum
specific for VPg or 3A as previously described (39). How-
ever, protein A-Sepharose was used in place of Staphylo-
coccus aureus cells. A VPg marker was prepared by labeling
a 100-ml suspension culture (4.5 x 105 cells per ml) with 5
,uCi of ['4C]lysine per ml 45 min after infection with PV1. At
6 h postinfection, the 14C-labeled cells were harvested, and
poliovirions were gradient purified as previously described
(29). The virions were denatured and treated with RNase A
and RNase T1 as described above, and 14C-labeled VPg-pUp
was immunoprecipitated with VPg-specific antiserum. Im-
munoprecipitated material was denatured for 5 min at 65°C
in loading buffer and electrophoresed in 13.5% bisacryla-
mide-cross-linked polyacrylamide gels (18). Gels were fixed
in 12% (vol/vol) acetic acid-40% (vol/vol) methanol, dried,
and exposed to Kodak X-Omat AR film.
Fractionation of viral RNA and poliovirions. R19 HeLa
cells in 6-cm dishes were transfected with 2 ,ug of RNA
transcribed from pT7-VPgl6, -17, -21, and -35. Cells were
labeled with 32Pi at a concentration of 125 ,uCi/ml as de-
scribed above. Clarified lysates were layered onto 30-ml 15
to 30% sucrose gradients containing a top layer of 1%
deoxycholate, 1% Brij 58, and 10% sucrose in reticulocyte
standard buffer plus Mg2+ (25). The gradients were centri-
fuged in an SW28 rotor at 53,000 x g for 16.7 h when
migration of RNA was assayed and at 89,000 x g for 2.5 h
when migration of poliovirions was assayed. Gradients were
fractionated, and trichloroacetic acid-precipitable counts
were measured. CsCl gradient-purified poliovirions, phenol-
chloroform-extracted virion RNA, and HeLa cell rRNA
were used as markers in the sucrose gradients.
RESULTS
Accumulation of poliovirus RNAs in transfected HeLa cells.
To determine the effect of mutations in VPg on RNA
replication, HeLa cells were transfected with full-length
transcripts, and at various times after transfection total
intracellular RNAs were recovered, denatured with formal-
dehyde, and immobilized on membranes. The immobilized
RNAs were separately identified by hybridization with 32p_
labeled polyribonucleotide probes as described in Materials
and Methods. The probes were specific for the detection of
negative- and positive-sense RNA and allowed analysis of
the kinetics of synthesis of the two species of viral RNA.
Dot blot autoradiograms are shown in Fig. 2A. RNAs of
mock-transfected cells yielded barely detectable dots. As
another negative control, RNAs of cells transfected with
transcripts from PvuII-digested pT7XL, in which a portion
of 3DPo1 and all of the 3'-nontranslated region are deleted,
yielded dots of an intensity similar to that of the dots of
mock-transfected cells, an observation confirming that the
remaining genetic elements were unable to direct synthesis
of viral RNA and that the amount of transfecting RNA by
itself was too low to yield a signal under the conditions
applied. On the other hand, all mutant RNAs, except VPg42,
can direct viral RNA replication. VPglS is a variant without
phenotype, which was expected since the KlOR change
yields a VPg that occurs in type 2 and type 3 polioviruses
(15, 16), whereas none of the mutant RNAs except VPg43
yielded viable virus in HeLa cells. It was apparent from the
hybridization signal intensities that in transfections with
nonviable mutants there was a lag period before RNA
replication commenced, and overall less RNA was synthe-
sized in comparison with PV1 (Mahoney) or VPgl5.
Of particular interest to us were mutations of tyrosine 3,
the amino acid that links VPg to the viral genome. Among
these was VPgl6, which carries an inversion of amino acids
3 and 4 (TY instead YT). Apparently, this mutation allows
RNA replication, albeit at an impaired level (Fig. 2A).
Absence of a tyrosine residue, as in mutant VPg42, abol-
ished RNA synthesis (Fig. 2A). Since VPg42 had additional
amino acid replacements, we constructed mutants in which
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FIG. 2. Quantitative comparison of viral RNA synthesis in transfected HeLa cells. (A and B) Dot blot hybridization of intracellular RNA
harvested at various times posttransfection. RNA samples were denatured, spotted on nylon membranes, and probed with equal levels of
32P-labeled polyribonucleotides specific for the 3' end of negative- and positive-sense poliovirus RNA. The initial number of cells in lysates
of all samples was 106.
only the third residue of VPg was changed to phenylalanine
[VPg(Y3F)] or serine [VPg(Y3S)]. Neither VPg(Y3S)- nor
VPg(Y3F)-transfected cells displayed viral RNA synthesis
(Fig. 2B), an observation proving the pivotal role of the
amino acid in position 3 of VPg.
Is the viral RNA linked to VPg? To determine whether viral
RNAs synthesized in transfected HeLa cells were linked at
their 5' termini to VPg, it was necessary to prepare poliovi-
rus RNA labeled to high specific activity with 32p. After
phenol-chloroform extraction to remove proteins not cova-
lently bound to the RNA (including intracellular free VPg-
pUpU; see below), the labeled material was digested with a
mixture of RNases T1 and A, two enzymes that degrade the
RNA to mono- and oligonucleotides with 3' phosphates. If
VPg was linked to newly synthesized RNA in transfected
cells, it could be identified as [32P]VPg-pUp after RNase
treatment (since the 5' end of VPg-linked RNA is VPg-
pUpU...) through immunoprecipitation and polyacrylamide
gel electrophoresis. Immunoprecipitations were carried out
with antisera specific for VPg or 3A (39). Immunoprecipita-
tion with antiserum specific for 3A did not yield a detectable
labeled product (Fig. 3A). RNAs linked to a VPg precursor
were not lost during phenol extraction of cell lysates (e.g.,
3AB-RNA entering the phenol phase), as unextracted mate-
rial examined in parallel with extracted samples also failed to
yield 32P-labeled material recognized by anti-3A (data not
shown). All the nonviable VPg mutants yielded material
immunoprecipitated by anti-VPg that migrated to the same
position as [14C]-lysine-labeled marker VPg-pUp (Fig. 3B).
The immunoprecipitated VPg-pUp is not derived from free
VPg-pUpU in the transfected cells, as extraction with phe-
nol-chloroform removed all VPg-pUpU from the lysates, a
phenomenon described previously by Ambros and Baltimore
(1, 2). Accordingly, immunoprecipitations with anti-VPg
sera after phenol-chloroform extraction but before nuclease
digestion did not yield VPg-pUpU in our experiments (data
not shown).
Assays for encapsidation of RNA. We next analyzed the
nature of the viral RNAs in transfected cells and whether
virus particles could be detected in gradients. For this
purpose, cellular lysates of HeLa and COS-1 cells trans-
fected with nonviable mutant RNAs were harvested at 20 h
posttransfection and analyzed on CsCl gradients. None of
the mutants yielded virions or empty capsids (data not
shown). Total RNAs of 32P-labeled cells transfected with
VPg16, -17, -21, and -35 were fractionated on 15 to 30%
sucrose gradients. Peaks of radioactivity corresponding to
free viral RNA were observed (Fig. 4A and B). However, no
virions were detected in cells transfected with the replica-
tion-positive, nonviable RNAs (Fig. 4C).
HeLa cells transfected with replication-positive, virus-
negative RNA were labeled with [35S]methionine from 8 to
20 h posttransfection in an attempt to analyze the proteolytic
processing of virus-specific proteins translated from the
nonviable RNAs. Whereas poliovirus proteins could be
detected by immunoprecipitation from extracts of cells
transfected with wild-type poliovirus RNA, no viral proteins
were observed when nonviable mutant RNAs were used
(data not shown). This observation suggests that viral pro-
tein synthesis may be severely impaired in mutant RNA-
transfected cells.
Four to six days after transfection with VPg16 and VPg18
transcripts, a small percentage of COS-1 cells in transfected
monolayers began to display cytopathic effect characteristic
of cells transfected with wild-type RNA, although no plaque-
forming particles could be recovered (data not shown). The
reason for the cytopathogenic effect is not known.
Recovery of a viable revertant. HeLa and COS-1 cells
transfected with the nonviable VPg mutant RNAs were
maintained for extended intervals to encourage production
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FIG. 3. Immunoprecipitation of poliovirus-specific proteins by VPg- and 3A-specific antiserum. Lysates were prepared from transfected
cells labeled with 32p;. The lysates were phenol extracted and treated with RNase A and RNase T1. Immunoprecipitations were done with
antiserum specific for 3A (A) or VPg (B), and immunoprecipitated material was electrophoresed in a 13.5% SDS-polyacrylamide gel.
['4C]lysine-labeled VPg and [35S]methionine-labeled poliovirus-infected HeLa cell extract are used as markers. The positions of 2A, 3AB, 3A,
and VPg are indicated to the right.
of viable revertants. We have recovered infectious virus 72 h
posttransfection from HeLa cells transfected with VPg17
RNA (Fig. 5). VPg17 was generated by introducing a G-to-A
substitution in the position 17 codon of the VPg-coding
region, a mutation resulting in an arginine-to-glutamine
substitution. The RNA sequence of the viable revertant
retained the nucleotide changes used to introduce restriction
sites into the mutagenesis cartridge but possessed the wild-
type codon at position 17 and thus has the genotype of
VPg15. Indeed, the plaque size of the revertant was similar
to that of VPg15 and XL virus (data not shown).
Substitution of coxsackievirus VPg for poliovirus VPg. The
replacement of poliovirus VPg with that of coxsackie B virus
yielded VPg43, a viable chimeric virus. The VPg of this virus
contained amino acids of CBV1, CBV3, and CBV4, a
fortuitous result of construction of the mutagenesis cartridge
(possibly due to mixtures in the oligonucleotides used)
and/or molecular cloning. Specifically, the valine residue at
position 6 corresponds to the VPg of coxsackievirus B3,
while the lysine residue at position 12 is found in the VPg of
coxsackieviruses Bi and B4. Cells transfected with chimeric
transcripts displayed cytopathic effect at 40 h posttransfec-
tion and were completely lysed by 60 h posttransfection.
VPg43 had a small-plaque phenotype (data not shown) and
replicated less efficiently than PV1 in one-step growth curve
experiments (Fig. 6). Production of VPg43 virus was 100 to
1,000 times lower than that of PV1 during the replication
cycle. As mentioned above, VPg42, a mutant with amino
acid replacements similar to those of VPg43 but with an
asparagine in position 3, was nonviable.
DISCUSSION
A poliovirus cDNA containing a mutagenesis cartridge
spanning the VPg-encoding region permitted rapid genera-
tion of site-specific mutations by insertion of complementary
oligonucleotides at unique restriction sites. Previous muta-
tional analyses of VPg function have identified amino acids
in the protein that can be replaced without loss of virus
production by transfected cells. However, generation of a
large number of nonviable mutants demonstrated that cer-
tain amino acids must be conserved if viability is to be
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maintained. Nonviable VPg mutants, none of which dis-
played a temperature-sensitive phenotype, were used in this
study to identify the step(s) in poliovirus replication that are
impaired or halted by changes of these amino acids.
To assay viral RNA synthesis in cells transfected with
RNAs encoding mutations in VPg, intracellular RNA was
harvested at various times posttransfection and probed with
poliovirus-specific polyribonucleotides. All nonviable RNAs
that encoded tyrosine in position 3 or 4 of VPg were
replicated in transfected HeLa cells. With most mutants,
selective inhibition against positive- or negative-sense RNA
synthesis was not apparent, although we repeatedly ob-
served a lag phase before RNA synthesis in cells transfected
with nonviable, RNA-positive mutants, and this lag ap-
peared to be more pronounced for negative-sense RNA.
Some of the mutants overcame the initial delay and ap-
proached the level of RNA synthesis displayed by cells
transfected with wild-type transcripts. VPg16, in which the
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FIG. 4. Fractionation of poliovirus RNA through 15 to 30%
sucrose in reticulocyte standard buffer plus Mg2". The bottoms of
the gradients are at the left. (A) Sedimentation of 32P-labeled HeLa
cell RNA and poliovirus virion RNA for 16.7 h at 53,000 x g in an
SW28 rotor. (B) HeLa cells were transfected with nonviable,
replication-positive VPg mutant RNA. 32P-labeled RNA was har-
vested from dactinomycin treated cells at 18 h posttransfection and
layered on the gradients. Centrifugation was as described for panel
A. (C) Cells were infected with poliovirus or transfected with mutant
RNA. At 7.5 h postinfection or 20 h posttransfection, lysates were
harvested from the 32P-labeled, dactinomycin-treated cells and
sedimented through the gradients for 2.5 h at 89,000 x g in an SW28
rotor.
tyrosine was moved from position 3 to 4, displayed marked
inhibition of both positive- and negative-sense RNA synthe-
sis. This may reflect impaired uridylylation of VPg due to a
change in the position of the linking amino acid and/or
defective priming of viral RNA synthesis. Overall, the
poliovirus RNA replication system displayed a remarkable
degree of tolerance for variation in VPg sequence, as long as
a tyrosine was available for linkage of the protein to RNA.
The high rate of RNA synthesis shown by the mutants
cannot be explained by reversion of the RNA sequences to
the wild type, as assays of cell medium collected during the
hybridization experiments did not detect plaque-forming
virus (data not shown). However, in separate experiments, a
viable revertant has been recovered from HeLa cells trans-
fected with VPg17 RNA after long-term incubation of the
plates. The revertant RNA retained the nucleotide changes
resulting from formation of unique restriction sites in the
VPg mutagenesis cartridge and encoded VPg molecules with
the primary structure of VPg15. We are currently searching
for revertants of other nonviable mutants. The low rate of
reversion exhibited by the nonviable, replication-positive
mutants has yet to be explained. Thus far, all attempts to find
second-site revertants have failed.
Labeling experiments revealed that VPg was linked to the
5' ends of the replication-positive, nonviable RNAs. The
presumed precursor of VPg, 3AB, was not found at the 5'
end of the nonviable RNAs synthesized in transfected cells.
If 3AB is involved in replication at all, cleavage of this
polypeptide may occur concomitant with, or before, uridy-
lylation of VPg.
Mutations that prevent VPg uridylylation (and thus link-
J. VIROL.
MUTATIONAL ANALYSIS OF POLIOVIRUS VPg 2973
VPg mutagenesis cartridge
Stu I Ava II
- 3C Pro
Ava I
TTGC GGTCACC+
AACG4CCAGTGG
GGAGCATACACTGGTTTACCAAACAA AGGCC CGTGCCCACCATT G GCAAAGGTACAI
CCTCGTATGTGACCAAATGGTTTGTT TCCGG TGCACGGGTGGTAA CCTG CGTTTCCATGTI
GCCCCGGCTTCG
CCGGGCCCAAGC
= 5450
AG HQ GAY T G L P N KR P NV PT I R T AK V Q G P G F
VPgl7 r VPg
--3C pro
W GCUGGUCACCACGGAGCAUACACUGGUUUACCAAACAAGAGGCCUAACGUGCCCACCAUU @ ACCGC,AAAGGUACAAGGCCCCGGGTTrCG
A G H Q G A Y T G L P N K R P N V P T I Q T A K V Q G P G F
Viable revertant of VPg17
* VPg 3C pro
UUGCUGGUCACCA4GGAGCAUACACUGGUUUACCAAACAAGAGGCCUAACGUGCCCACCAUUCGGACCGCAAAGGUACAAkGCCCCGGGTrrCG
A G VI Q G A Y T G L P N K R P N V P T I R T A K V Q G P G F
FIG. 5. Structure of the VPg mutagenesis cartridge and the nucleotide sequence of nonviable VPg17 RNA and the viable VPg17-specific
revertant. Nucleotide sequences shown correspond to nucleotides 5357 through 5450 of the poliovirus type 1 (Mahoney) genome. Nucleotide
substitutions resulting from introduction of restriction sites into the mutagenesis cartridge are denoted by asterisks above the nucleotides. The
G-to-A nucleotide substitution used to generate VPg17 is boxed in the VPg17 sequence. The amino acid sequence of the corresponding region
of the PV1 polyprotein is given below each nucleotide sequence in the one-letter amino acid code.
age of VPg to RNA) abolish synthesis of viral RNA in
transfected cells, and this was found to be true for the three
amino acid replacements Y3F, Y3S, and Y3N. Mutant
VPg(Y3S) was particularly interesting to us because serine is
11 -
10 -
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Q-
0)
0
9.
8-
7.-
6-
5-
3 4 5 6
Hours Post-infection
FIG. 6. One-step growth curve of poliovirus type 1 (Mahoney)
and the VPg43 mutant virus. HeLa cell monolayers were infected at
a multiplicity of infection of 25 and incubated at 37°C. At various
times postinfection, cells were harvested and virus production was
measured by plaque assay. Data are plotted as the virus titer (logl0
PFU per milliliter) versus hours postinfection.
the linking amino acid in VPg of cowpea mosaic virus RNA
(46) and also in the terminal protein of adenovirus DNA (4).
However, the poliovirus replication system does not appear
to allow substitution of tyrosine with serine. VPg(T3F) was
undoubtedly nonviable and RNA replication defective be-
cause of the absence of a phenolic hydroxyl group with
which a phosphodiester could be formed with the 5'-terminal
uridylic acid. An essential role for tyrosine is likely for all
picornavirus VPgs, since in all cases the tyrosine in position
3 is conserved (3). Together with the analyses of the 5'
termini of viral RNA isolated after transfection, these results
support the hypothesis that a uridylylation-competent VPg is
essential in poliovirus RNA synthesis.
A function of VPg other than involvement in RNA syn-
thesis may be defective in the mutants that were RNA
replication positive but nonviable. Genomic masking exper-
iments are under way to examine the possible role of VPg in
the encapsidation of viral RNA (43). The hypothesis to be
tested is whether VPg can serve as a specific signal for
packaging of RNA into capsids. We must entertain, how-
ever, a more trivial explanation, which is that defective
virus-specific protein synthesis in mutant-transfected cells
may result in levels of capsid proteins inadequate for pro-
duction of virions. Indeed, [35S]methionine-labeled viral
proteins could not be detected in immunoprecipitates of cells
transfected with the RNA replication-positive, nonviable
mutants.
Mutants VPg37 and VPg35 are the most difficult to com-
prehend. VPg37 contains an insertion in polypeptide 3A, and
its VPg is identical to that of VPg15, which replicates with
wild-type kinetics. Since transfection with VPg37 produced
VPg15-like, VPg-linked RNA, why was this RNA not encap-
o VPg
BstE 11
- VPg43
* WT
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sidated? The insertion in 3A may result in defective interac-
tion of 3AB with the membranous replication complex; the
perturbation of 3AB function could be responsible for an
impairment in encapsidation. In VPg35, the cleavage site
AXXQ*G at the C terminus of VPg was changed to
KXXQ*G, which is considered the least favorable of all
cleavage sequences (22). This mutant produced VPg-linked
RNA; however, as VPg35 produced no cleavage between 3B
and 3CD in vitro (16), processing may take place at an
impaired level in vivo.
Replacement of poliovirus VPg with that of coxsackievi-
rus yielded a viable chimeric virus that did not replicate as
efficiently as wild-type poliovirus. This is probably not due
to a host cell restriction of virus multiplication, as multipli-
cation of coxsackievirus strains is supported by R19 HeLa
cells. Rather, the defect in multiplication may be due to an
impairment of interaction between PV1 proteins and the
heterologous VPg.
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